This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2010 Sep;6(9):502-3.

doi: 10.1038/nrrheum.2010.137.

Bone: Do all Paget disease risk genes incriminate the osteoclast?

Frederick R Singer¹, Robin J Leach

Affiliations

Affiliation

¹ Endocrine/Bone Disease Program, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA. singerf@yahoo.com

PMID: 20808305
DOI: 10.1038/nrrheum.2010.137

Bone: Do all Paget disease risk genes incriminate the osteoclast?

Frederick R Singer et al. Nat Rev Rheumatol. 2010 Sep.

. 2010 Sep;6(9):502-3.

doi: 10.1038/nrrheum.2010.137.

Authors

Frederick R Singer¹, Robin J Leach

Affiliation

¹ Endocrine/Bone Disease Program, John Wayne Cancer Institute at Saint John's Health Center, 2200 Santa Monica Boulevard, Santa Monica, CA 90404, USA. singerf@yahoo.com

PMID: 20808305
DOI: 10.1038/nrrheum.2010.137

No abstract available

PubMed Disclaimer

Similar articles

Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease.
Kurihara N, Hiruma Y, Zhou H, Subler MA, Dempster DW, Singer FR, Reddy SV, Gruber HE, Windle JJ, Roodman GD. Kurihara N, et al. J Clin Invest. 2007 Jan;117(1):133-42. doi: 10.1172/JCI28267. Epub 2006 Dec 21. J Clin Invest. 2007. PMID: 17187080 Free PMC article.
The majority of the genetic risk for Paget's disease of bone is explained by genetic variants close to the CSF1, OPTN, TM7SF4, and TNFRSF11A genes.
Chung PY, Beyens G, Boonen S, Papapoulos S, Geusens P, Karperien M, Vanhoenacker F, Verbruggen L, Fransen E, Van Offel J, Goemaere S, Zmierczak HG, Westhovens R, Devogelaer JP, Van Hul W. Chung PY, et al. Hum Genet. 2010 Dec;128(6):615-26. doi: 10.1007/s00439-010-0888-2. Epub 2010 Sep 14. Hum Genet. 2010. PMID: 20839008
Genetics of Paget's disease of bone.
Ralston SH, Albagha OM. Ralston SH, et al. Curr Osteoporos Rep. 2014 Sep;12(3):263-71. doi: 10.1007/s11914-014-0219-y. Curr Osteoporos Rep. 2014. PMID: 24988994 Review.
Recent advances in understanding the molecular basis of Paget disease of bone.
Goode A, Layfield R. Goode A, et al. J Clin Pathol. 2010 Mar;63(3):199-203. doi: 10.1136/jcp.2009.064428. Epub 2009 Oct 26. J Clin Pathol. 2010. PMID: 19858527 Review.
[Paget disease of bone].
Okada K, Takahashi S, Nagasawa H, Itoi E. Okada K, et al. Nihon Rinsho. 2006 Jun 28;Suppl 2:139-42. Nihon Rinsho. 2006. PMID: 16817369 Review. Japanese. No abstract available.

See all similar articles

Cited by

The osteoclast--what's new?
Athanasou NA. Athanasou NA. Skeletal Radiol. 2011 Sep;40(9):1137-40. doi: 10.1007/s00256-011-1180-9. Epub 2011 Aug 17. Skeletal Radiol. 2011. PMID: 21847745 Review.
HDAC6 regulates dental mesenchymal stem cells and osteoclast differentiation.
Wang Y, Shi ZY, Feng J, Cao JK. Wang Y, et al. BMC Oral Health. 2018 Nov 21;18(1):190. doi: 10.1186/s12903-018-0624-1. BMC Oral Health. 2018. PMID: 30463548 Free PMC article.
Visomitin Attenuates Pathological Bone Loss by Reprogramming Osteoclast Metabolism via the STAT3/LDHB Axis.
Yuan P, Feng Z, Yang H, Xue H, Xie H, Dai Z, Wang H, Liu Y, Pan B, Song H, Ye H, Xie Z, Shi P, Sun X. Yuan P, et al. Research (Wash D C). 2025 Jul 22;8:0784. doi: 10.34133/research.0784. eCollection 2025. Research (Wash D C). 2025. PMID: 40698330 Free PMC article.
Sigma-1 receptor attenuates osteoclastogenesis by promoting ER-associated degradation of SERCA2.
Wei X, Zheng Z, Feng Z, Zheng L, Tao S, Zheng B, Huang B, Zhang X, Liu J, Chen Y, Zong W, Shan Z, Fan S, Chen J, Zhao F. Wei X, et al. EMBO Mol Med. 2022 Jul 7;14(7):e15373. doi: 10.15252/emmm.202115373. Epub 2022 May 25. EMBO Mol Med. 2022. PMID: 35611810 Free PMC article.

References

1. Expert Rev Mol Med. 2009 Jul 29;11:e23 - PubMed
1. J Clin Endocrinol Metab. 2009 Feb;94(2):691-4 - PubMed
1. J Bone Miner Res. 2009 Mar;24(3):484-94 - PubMed
1. QJM. 2002 Apr;95(4):233-40 - PubMed
1. Science. 2002 Feb 8;295(5557):1077-9 - PubMed

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information